Hou Yilin, Zhou Man, Xie Jing, Chao Ping, Feng Qiyu, Wu Jun
Department of Endocrinology, The Third Hospital of Wuhan (Tongren Hospital of Wuhan University), Wuhan, People's Republic of China.
Eastern Hepatobiliary Surgery Institute, National Center for Liver Cancer, Shanghai, People's Republic of China.
Breast Cancer (Dove Med Press). 2017 Jun 13;9:429-436. doi: 10.2147/BCTT.S135665. eCollection 2017.
Hyperglycemia or diabetes mellitus (DM), which is characterized by high blood glucose levels, has been linked to an increased risk of cancer for years. However, the underlying molecular mechanisms of the pathophysiological link are not yet fully understood. In this study, we demonstrate that high glucose levels promote the proliferation of breast cancer cells by stimulating epidermal growth factor receptor (EGFR) activation and the Rho family GTPase Rac1 and Cdc42 mediate the corresponding signaling induced by high glucose levels. We further show that Cdc42 promotes EGFR phosphorylation by blocking EGFR degradation, which may be mediated by the Cbl proteins, whereas the Rac1-mediated EGFR phosphorylation is independent of EGFR degradation. Our findings elucidate a part of the underlying molecular mechanism of the link between high glucose levels and tumorigenesis in breast cancer and may provide new insights on the therapeutic strategy for cancer patients with diabetes or hyperglycemia.
高血糖症或糖尿病(DM),其特征为血糖水平升高,多年来一直与癌症风险增加有关。然而,病理生理联系的潜在分子机制尚未完全阐明。在本研究中,我们证明高糖水平通过刺激表皮生长因子受体(EGFR)激活来促进乳腺癌细胞增殖,并且Rho家族GTP酶Rac1和Cdc42介导高糖水平诱导的相应信号传导。我们进一步表明,Cdc42通过阻断EGFR降解来促进EGFR磷酸化,这可能由Cbl蛋白介导,而Rac1介导的EGFR磷酸化与EGFR降解无关。我们的研究结果阐明了高糖水平与乳腺癌肿瘤发生之间联系的部分潜在分子机制,并可能为糖尿病或高血糖症癌症患者的治疗策略提供新的见解。